St. Jude ICD, Tissue Valve Differentiation Will Fall To Incoming CEO Starks
This article was originally published in The Gray Sheet
Executive Summary
Incoming Chairman and CEO Daniel Starks will direct St. Jude Medical's efforts to catch up with established players in the tissue valve and cardiac resynchronization therapy defibrillator markets